Page last updated: 2024-08-24

meglumine antimoniate and Leishmaniasis

meglumine antimoniate has been researched along with Leishmaniasis in 134 studies

Research

Studies (134)

Timeframe	Studies, this research(%)	All Research%
pre-1990	40 (29.85)	18.7374
1990's	21 (15.67)	18.2507
2000's	26 (19.40)	29.6817
2010's	32 (23.88)	24.3611
2020's	15 (11.19)	2.80

Authors

Authors	Studies
Gürses, G; Kurt, Ö; Öktem Okullu, S; Toprak, Ş; Yentür Doni, N; Yıldız Zeyrek, F	1
Andreazza Costa, MC; Borsodi, MPG; Cabral Abreu Grijó, B; Castro Ferreira, MM; Costa, AV; Lima, WP; Rodrigues Gazolla, PA; Rossi Bergmann, B; Teixeira, RR	1
Almani, PGN; Bamorovat, M; Salari, S; Sharifi, I	1
Becattini, L; Ferrari, F; Masserdotti, C; Ottaiano, P; Tamborini, A; Tiozzo, AA	1
Abreu, F; Lima, F; Nico, D; Taveira, I; Verdan, M	1
Broere, F; de Jong, MK; Piek, CJ; Rappoldt, A	1
Botura Scariot, D; Conceição da Silva, C; de Oliveira Silva, S; Falzirolli, H; Graça Contato, A; Kaplum, V; Pelegrin Garcia, F; Ueda-Nakamura, T; Vandresen, F; Vataru Nakamura, C	1
Friedman, A; Siewe, N	1
Akulinina, I; Berechikidze, I; Burdaev, N; Grinev, A; Larina, S	1
Castro, MDM; Cossio, A; Fernández, O; Gallego-Marín, C; Gómez, MA; McMahon-Pratt, D; Murillo, J; Navas, A; Rosales-Chilama, M; Saravia, NG	1
Azinheira, S; Campino, L; Cristovão, JM; Maia, C; Parreira, R; Pereira, A; Valente, J	1
da Silva, JHM; de Barros, NB; de Figueiredo Nicolete, LD; Dos Santos Ferreira, A; Macedo, SRA; Nicolete, R; Valentim-Silva, JR	1
Alves, MLR; Bandeira, CC; de Faria, BG; Giunchetti, RC; Peruhype-Magalhães, V; Ribeiro, JM; Souza-Fagundes, EM; Teixeira-Carvalho, A; Uzonna, JE; Vieira, FO	1
Ayala, TS; Banhuk, FW; Cabral, IL; de Amorim, JPA; Gandra, RF; Loth, EA; Menolli, RA; Negretti, F; Staffen, IV; Utzig, SL	1
Barbè, F; Ibba, F; Paltrinieri, S; Rossi, G	1
Chatzis, MK; Kasabalis, D; Saridomichelakis, MN; Steiner, JM; Suchodolski, JS; Xenoulis, PG	1
Bomfim, LGS; de Almeida, RP; de Jesus, AR; de Moura, TR; Dos Santos, PL; Lipscomb, MW; Magalhães, LS; Santos, CNO; Tanajura, DM	1
Damrose, E; Fernandes, AM; Silva, L	1
Burchmore, R; Ceron, JJ; Escribano, D; Horvatic, A; Kocaturk, M; Martinez-Subiela, S; Mrljak, V; Pardo-Marin, L; Yilmaz, Z	1
Akhtar, S; Ashraf, S; Hussain, I; Hussain, SZ; Rafay, M; Sarwar, HS; Shahnaz, G; Sohail, MF; Yasinzai, M	1
Cantos-Barreda, A; Cerón, JJ; Escribano, D; Martínez-Subiela, S; Pardo-Marín, L; Segarra, S	1
Carvalho, AM; Carvalho, EM; Carvalho, LP; Lago, ASD; Lago, N; Machado, P; Nascimento, M; Queiroz, JR; Schriefer, A; Silva, J; Wilson, M	1
Gómez, S; Palacio, MJF; Santarelli, G; Sebastián-Marcos, P	1
Andrade, HF; Borborema, SE; Nascimento, Nd; Osso, JA	1
Giordano, A; Ibba, F; Meazzi, S; Paltrinieri, S; Rossi, G	1
Diaz-Toro, Y; Fernández, OL; Gomez, MA; Muvdi, S; Ovalle, C; Rodríguez, I; Saravia, NG; Valderrama, L	1
Baptista, C; Conceição-Silva, F; Leon, LL; Madeira, Mde F; Miranda, Lde F; Schubach, Ade O	1
Cerrone, A; Corso, R; Galiero, G; Gravino, AE; Manna, L; Muzj, P	1
Fernández, OL; Gonzalez-Fajardo, L; McMahon-Pratt, D; Saravia, NG	1
Acedo-Sánchez, C; Corpas-López, V; Díaz-Sáez, V; Martín-Sánchez, J; Merino-Espinosa, G; Morillas-Márquez, F	1
Alborch, L; Montserrat-Sangrà, S; Ordeix, L; Solano-Gallego, L	1
Cerón, JJ; Escribano, D; Kocaturk, M; Martínez-Subiela, S; Pardo-Marín, L; Torrecillas, A; Tvarijonaviciute, A; Yilmaz, Z	1
Abamor, ES; Allahverdiyev, AM; Bagirova, M; Rafailovich, M	1
Cerón, JJ; Garcia-Martinez, JD; Martínez-Subiela, S; Pardo-Marín, L; Pastor, J; Segarra, S; Tvarijonaviciute, A	1
De Majo, M; Lo Giudice, S; Masucci, M; Pennisi, MG; Reale, S; Vitale, F	1
de Paula-Coelho, VN; Muniz-Junqueira, MI	1
Foglia Manzillo, V; Gradoni, L; Guglielmino, R; Oliva, G; Pagano, A; Restucci, B	1
Bianciardi, P; Mateo, M; Maynard, L; Miró, G; Vischer, C	1
Arnedo-Pena, A; Bellido-Blasco, JB; Herrero-Carot, C; Romeo-García, MA	1
Bertazzolo, W; Dell'Orco, M; Paccioretti, F	1
Boutaleb-Charki, S; Díaz, JG; Guitierrez-Sánchez, R; Huertas, O; Marín, C; Pérez-Cordon, G; Rosales, MJ; Sánchez-Moreno, M	1
Aresu, L; Bianciardi, P; Brovida, C; Castagnaro, M; Cavicchioli, L; Giroud, L; Valente, M; Vischer, C	1
Lamothe, J	1
Cavassini, M; Cometta, A; Foguena, AK; Greub, G; Schroeder, D	1
Bardagí, M; Ferrer, L; Ravera, I; Roura, X; Torres, M; Zanna, G	1
Hajiabdolbaghi, M; Hajjaran, H; Hashemian, H; Jafari, S; Mohebali, M	1
Demicheli, C; Frézard, F	1
Dobakhti, F; Khalili, G; Khaze, V; Mahmoudzadeh-Niknam, H; Partovi, F	1
Descalzo, MA; Fraile, C; Gálvez, R; Miró, G; Molina, R	1
Borborema, SE; de Andrade, HF; do Nascimento, N; Osso, JA; Schwendener, RA	1
Amato, ME; De Palo, P; Greco, B; Lubas, G; Paradies, P; Sasanelli, M	1
Castillo, H; Diaz-Toro, Y; Fernández, O; Ovalle, C; Perez, M; Saravia, NG; Valderrama, L; Valderrama, M	1
Forouzannia, SK; Pourrajab, F; Tabatabaee, SA	1
Baker, NC; Blanco, V; Craft, N; Garcerant, D; Martinez, J; Rubiano, L	1
Calla-Magariños, J; Fernández, C; Freysdottir, J; Giménez, A; Quispe, T; Troye-Blomberg, M	1
Almeida Catanho, MT; Amorim, LF; Bernardo-Filho, M; Brandao, KC; Cavalcanti Jales, RL; de Brito Tiago, GG; Gomes, ML; Holanda Leite, RC; Jales-Junior, LH; Lopes de Brito, LM; Xavier Holanda, CM	1
Alvarez, N; Le Baut, G; Le Pape, P; Robert, JM; Robledo, S; Velez, ID	1
NOGUER MORE, S	1
BOIX BARRIOS, J	1
BERNARD, R; GIRAUD, P; VINCENT, P	1
FLOCH, H	1
CORNEJO, A	2
MATOS, J; VELASCO, JA	1
CARVALHO, O	1
PI FERRER, A; SALA GINABREDA, JM; WOESSNER CASAS, S	1
CAMBI, P	1
ESCHER, D; LAHAM, E	1
DURAND, P	1
BOULARD, C; MASSONNAT, J; PORTIER, A	1
RIPA, F; TONDI, IV	1
Diaz-Bertrana, MC; Durall, I; Franch, J; Lafuente, P; Munilla, A; Pastor, J; Torrent, E	1
Arango, G; Jaramillo, LM; Muñoz, D; Osorio, E; Restrepo, A; Robledo, S; Vélez, I	1
Aceña, MC; Castillo, JA; Gascón, M; Gómez-Ochoa, P; Miana-Mena, FJ	1
de Oliveira, FB; Demicheli, C; Dzamitika, SA; Falcão, CA; Frézard, F; Garnier-Suillerot, A; Marbeuf, C; Rossi-Bergmann, B	1
de Castro Pimenta, AM; Demicheli, C; dos Santos Ferreira, C; Frézard, F	1
Cortes, S; João, A; Pereira, MA; Santos-Gomes, GM	1
Soto, J; Soto, P	1
Bouvresse, S; Crickx, B; Descamps, V; Devillière, M; Mahé, E; Marinho, E; Matichard, E; Soria, A	1
Gravino, AE; Manna, L; Pavone, LM; Picillo, E; Reale, S; Vitale, F	1
de Moura, FJ; de Souza Furtado, R; Leal, PP; Muniz-Junqueira, MI; Veiga, JP	1
Baron, AR; Del Pilar Mahecha, M; Dueñes, B; Montaña, R; Montero, LM; Reithinger, R; Sanchez, BF; Vega, JC	1
Alonso, C; Castilla, J; Fuertes, MA; Nguewa, PA; Pérez, JM	1
Steck, EA	1
Fisher, BK; Schewach-Millet, M; Semah, D	1
Heimgartner, E	1
Hidalgo, H; Solano, E; Zeledón, R	1
Armas, JA; Moreno, G; Rezzano, S; Scorza, JV	1
Chapman, WL; Hanson, WL; Hendricks, LD	1
Avila, JL; Biondo, F; Convit, J; Monzón, H	1
Belloli, C; Carli, S; Ceci, L; De Natale, G; Marcotrigiano, G; Montesissa, C; Ormas, P; Tassi, P	1
Añez, N; Burguera, JL; Burguera, M; Lugo de Yarbuh, A; Petit de Peña, Y	1
Evans, TG	1
Barbieri, CL; Cantos, G; Gorin, PA; Iacomini, M; Travassos, LR	1
Barrios, AA; Bruneton, J; Cavé, A; Fournet, A; Hocquemiller, R; Muñoz, V	1
Evans, TG; Hibbs, JB; Reed, SS	1
Slappendel, RJ; Teske, E	1
Alberola, J; Arboix, M; Cristofol, C; Franquelo, C; Freixas, J; Valladares, JE	1
García Salazar, MA; Jiménez Martín, MJ; López Martínez, J; Temprano Vázquez, S	1
Amusategui, I; Sainz, A; Tesouro, MA	1
Agostoni, C; Dorigoni, N; Malfitano, A; Migliorini, D; Scaglia, M	1
Carvalho, S; de Figueiredo, TL; Demicheli, C; Frézard, F; Lopes, JC; Sinesterra, RD	1
Atienza Fernández, F; Castelló Viguer, MT; Cuesta Estellés, G; Echánove Errazti, I; Esteban Esteban, E; Ridocci Soriano, F	1
Panadés, MJ; Porcel, JM; Rubio, M; Sacristán, O	1
Miekeley, N; Mortari, SR; Schubach, AO	1
Aste, N; Biggio, P; Pau, M	1
Carrió, J; Portús, M	1
Kürkçüoğlu, N; Tandoğdu, R	1
Ellis, WY; Jackson, JE; Lawyer, PG; Limmer, BL; Mebrahtu, YB; Panisko, DM; Reed, SG; Tally, JD; Were, JB	1
Dedet, JP	1
De Rivera, MV; Franke, ED; Kruger, JH; Lucas, CM; Tovar, AA; Wignall, FS	1
Goerttler, E; Krutmann, J; Rzany, B; Schöpf, E	1
Dorea, JG; Holzbecher, J; Merchan-Hamann, E; Ryan, DE	1
Hanson, WL; Klayman, DL; Lovelace, JK; Vennerstrom, JL; Waits, VB	1
Arana, BA; Arana, FE; Castillo, AL; de Mérida, AM; Navin, TR; Pozuelos, JL	1
Vion, B	1
Jackson, JE; Tally, JD; Tang, DB	1
Castellanos, PL; Castes, M; Convit, J; Martinez, A; Moros, Z; Rondon, AJ; Trujillo, D	1
de Vásquez, AM; Johnson, CM; Narvaez, E; Paz, HM; Sáenz, RE	1
Marsden, PD; Sampaio, JH; Sampaio, RN	1
Santrich, C; Saravia, NG; Valderrama, L; Weigle, KA	1
Bloom, B; Castellanos, PL; Castes, M; Convit, J; Garcia, L; Pinardi, ME; Rondon, A; Ulrich, M	1
Kumar, PV; Sadeghi, E; Torabi, S	1
Anciaux, ML; Bourée, P; Taugourdeau, P	1
Chong, H	1
Lambert, D; Mambre, B	1
Benderitter, T; Casanova, P; Nashkidachvili, L; Quilici, M	1
Castro Coto, A; Coto Chacón, F; Hidalgo Hidalgo, H; Solano Aguilar, E	1
Desjeux, P; Le Pont, F; Mollinedo, S; Paredes, A; Ugarte, G	1
Alfred, C; Brandicourt, O; Gentilini, M; Mazier, D; Monjour, L; Nzuzi, KK; Ploton, I; Tselentis, Y; Vouldoukis, I	1
Belazzoug, S; Neal, RA	1
Aranzazu, N; Castellanos, PL; Convit, J; Pinardi, ME; Reyes, O; Ulrich, M	1
el-On, J; Kernbaum, S; Rubinstein, N; Schnur, LF	1
Barral, A; Barreto, AC; Carvalho, EM; Costa, JM; Cuba, CC; Llanos-Cuentas, EA; Magalhães, AV; Marsden, PD; Netto, EM; Rosa, AC	1

Reviews

10 review(s) available for meglumine antimoniate and Leishmaniasis

Article	Year
Global distribution of treatment resistance gene markers for leishmaniasis. Journal of clinical laboratory analysis, 2022, Volume: 36, Issue:8 Topics: Antimony Sodium Gluconate; Antiprotozoal Agents; Biomarkers; Drug Resistance; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Meglumine Antimoniate	2022
Drugs and nanoformulations for the management of Expert opinion on therapeutic patents, 2023, Volume: 33, Issue:3 Topics: Antiprotozoal Agents; Humans; Leishmania; Leishmaniasis; Meglumine Antimoniate; Patents as Topic	2023
New delivery strategies for the old pentavalent antimonial drugs. Expert opinion on drug delivery, 2010, Volume: 7, Issue:12 Topics: Administration, Oral; Administration, Topical; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Delivery Systems; Humans; Leishmaniasis; Liposomes; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2010
[Current situation and future of antileishmanial therapy in Colombia]. Biomedica : revista del Instituto Nacional de Salud, 2006, Volume: 26 Suppl 1 Topics: Antimony; Antiprotozoal Agents; Colombia; Forecasting; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2006
Anticancer compounds as leishmanicidal drugs: challenges in chemotherapy and future perspectives. Current medicinal chemistry, 2008, Volume: 15, Issue:5 Topics: Amsacrine; Animals; Antineoplastic Agents; Antiprotozoal Agents; Apoptosis; Humans; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Organoplatinum Compounds; Oxyquinoline; Phospholipids; Topoisomerase II Inhibitors	2008
The chemotherapy of protozoal infections: whither? The Journal of protozoology, 1981, Volume: 28, Issue:1 Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Disease Models, Animal; Glycolipids; Humans; Leishmaniasis; Leishmaniasis, Visceral; Liposomes; Lysosomes; Malaria; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Primaquine; Protozoan Infections; Trypanosomiasis	1981
Leishmaniasis. Infectious disease clinics of North America, 1993, Volume: 7, Issue:3 Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Child, Preschool; Female; Humans; Leishmania; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Protozoan Vaccines; Vaccination	1993
Cutaneous leishmaniasis in French Guiana: a review. The American journal of tropical medicine and hygiene, 1990, Volume: 43, Issue:1 Topics: Animals; Antiprotozoal Agents; Disease Reservoirs; French Guiana; Humans; Insect Vectors; Leishmania braziliensis; Leishmania mexicana; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Psychodidae	1990
Oriental sore. A look at trends in and approaches to the treatment of leishmaniasis. International journal of dermatology, 1986, Volume: 25, Issue:10 Topics: Allopurinol; Aminoquinolines; Antimony; Antimony Sodium Gluconate; Cryosurgery; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous; Levamisole; Liposomes; Meglumine; Meglumine Antimoniate; Metronidazole; Nifurtimox; Organometallic Compounds; Phenothiazines; Rifampin	1986
[Treatment of cutaneous leishmaniasis]. Annales de dermatologie et de venereologie, 1988, Volume: 115, Issue:5 Topics: Antiprotozoal Agents; Humans; Hyperthermia, Induced; Immunotherapy; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1988

Trials

8 trial(s) available for meglumine antimoniate and Leishmaniasis

Article	Year
Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol. Parasites & vectors, 2015, May-28, Volume: 8 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leishmania; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine; Retrospective Studies	2015
Clinical efficacy of two different drug combinations for the treatment of canine leishmaniasis. Veterinary research communications, 2008, Volume: 32 Suppl 1 Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Leishmaniasis; Meglumine; Meglumine Antimoniate; Metronidazole; Organometallic Compounds; Spiramycin; Treatment Outcome	2008
Monitoring the reverse to normal of clinico-pathological findings and the disease free interval time using four different treatment protocols for canine leishmaniosis in an endemic area. Research in veterinary science, 2012, Volume: 93, Issue:2 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Endemic Diseases; Female; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Time Factors	2012
The effect of intravenous or subcutaneous administration of meglumine antimonate (Glucantime) in dogs with leishmaniasis. A randomized clinical trial. The veterinary quarterly, 1997, Volume: 19, Issue:1 Topics: Animals; Antimony; Antiprotozoal Agents; Disease-Free Survival; Dog Diseases; Dogs; Female; Injections, Intravenous; Injections, Subcutaneous; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Remission Induction; Treatment Outcome	1997
Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala. The American journal of tropical medicine and hygiene, 1990, Volume: 42, Issue:1 Topics: Adult; Animals; Antimony; Antiprotozoal Agents; Follow-Up Studies; Guatemala; Hot Temperature; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Military Personnel; Organometallic Compounds; Radio Waves; Randomized Controlled Trials as Topic; Sorbitol	1990
Cell-mediated immunity in localized cutaneous leishmaniasis patients before and after treatment with immunotherapy or chemotherapy. Parasite immunology, 1989, Volume: 11, Issue:3 Topics: Adult; Antigens, Protozoan; BCG Vaccine; Clinical Trials as Topic; Female; Humans; Immunity, Cellular; Immunotherapy; Leishmaniasis; Leukocytes; Lymphocyte Activation; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin Tests	1989
Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis. Lancet (London, England), 1987, Feb-21, Volume: 1, Issue:8530 Topics: Adolescent; Adult; Antibodies; Antigens, Protozoan; Antiprotozoal Agents; Child; Clinical Trials as Topic; Female; Humans; Immunotherapy; Leishmania mexicana; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mycobacterium bovis; Organometallic Compounds; Random Allocation; Skin Tests; Sorbitol; Vaccination	1987
Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1986, Volume: 80, Issue:4 Topics: Adolescent; Algeria; Antimony; Antiprotozoal Agents; Child; Clinical Trials as Topic; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1986

Other Studies

116 other study(ies) available for meglumine antimoniate and Leishmaniasis

Article	Year
[In Vitro Efficacy of the Venome of Black Scorpion (Androctonus crassicauda) on Leishmania tropica Promastigotes]. Mikrobiyoloji bulteni, 2021, Volume: 55, Issue:4 Topics: Animals; Antiprotozoal Agents; Humans; Leishmania tropica; Leishmaniasis; Meglumine Antimoniate; Scorpions	2021
Eugenol derivatives with 1,2,3-triazole moieties: Oral treatment of cutaneous leishmaniasis and a quantitative structure-activity relationship model for their leishmanicidal activity. Experimental parasitology, 2022, Volume: 238 Topics: Animals; Antiprotozoal Agents; Eugenol; Female; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Meglumine Antimoniate; Mice; Quantitative Structure-Activity Relationship; Structure-Activity Relationship; Triazoles	2022
Long-term follow-up of a case of feline leishmaniosis treated with a combination of allopurinol and meglumine antimoniate. The Canadian veterinary journal = La revue veterinaire canadienne, 2023, Volume: 64, Issue:3 Topics: Acute Kidney Injury; Allopurinol; Animals; Cat Diseases; Cats; Follow-Up Studies; Leishmaniasis; Meglumine Antimoniate	2023
Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy. Parasites & vectors, 2023, May-15, Volume: 16, Issue:1 Topics: Allopurinol; Animals; Creatinine; Dog Diseases; Dogs; Humans; Leishmania infantum; Leishmaniasis; Leishmaniasis, Visceral; Meglumine Antimoniate; Prognosis; Recurrence; Urea	2023
Antiproliferative Activity and Ultrastructural Changes in Promastigote and Amastigote forms of Leishmania amazonensis Caused by Limonene-Acylthiosemicarbazide Hybrids. Chemistry & biodiversity, 2023, Volume: 20, Issue:7 Topics: Animals; Antiprotozoal Agents; Humans; Leishmania; Leishmaniasis; Limonene; Macrophages; Meglumine Antimoniate; Mice; Mice, Inbred BALB C	2023
Treatment of leishmaniasis with chemotherapy and vaccine: a mathematical model. Journal of biological dynamics, 2023, Volume: 17, Issue:1 Topics: Antimony Sodium Gluconate; Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine Antimoniate; Models, Biological; Vaccines	2023
[COMPARATIVE EFFICACY OF DOXYCYCLINE AND GLUCANTIME IN THE TREATMENT OF LEISHMANIASIS IN VITRO]. Georgian medical news, 2019, Issue:291 Topics: Doxycycline; Humans; In Vitro Techniques; Leishmaniasis; Meglumine Antimoniate	2019
Profiles of Local and Systemic Inflammation in the Outcome of Treatment of Human Cutaneous Leishmaniasis Caused by Infection and immunity, 2020, 02-20, Volume: 88, Issue:3 Topics: Antiprotozoal Agents; Cytokines; Gene Expression Profiling; Humans; Immunity, Innate; Leishmania; Leishmaniasis; Leukocytes, Mononuclear; Meglumine Antimoniate; Monocyte Chemoattractant Proteins; Monocytes	2020
An Unusual Case of Feline Leishmaniosis With Involvement of the Mammary Glands. Topics in companion animal medicine, 2019, Volume: 37 Topics: Allopurinol; Animals; Antiprotozoal Agents; Cat Diseases; Cats; Female; Leishmania donovani; Leishmaniasis; Leukemia Virus, Feline; Leukemia, Feline; Mammary Glands, Animal; Meglumine Antimoniate; Portugal; Uveitis	2019
Antileishmanial drugs activate inflammatory signaling pathways via toll-like receptors (docking approach) from Leishmania amazonensis-infected macrophages. International immunopharmacology, 2020, Volume: 85 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Inflammation; Leishmania; Leishmaniasis; Macrophages; Meglumine Antimoniate; Mice; Mitogen-Activated Protein Kinases; Molecular Docking Simulation; Pentamidine; Signal Transduction; Toll-Like Receptors; Transcription Factor RelA	2020
An ex vivo multiparametric flow cytometry assay using human whole blood to simultaneously measure cytotoxicity and leishmanicidal activities. Experimental parasitology, 2020, Volume: 216 Topics: Adult; Amphotericin B; Animal Testing Alternatives; Animals; Antiprotozoal Agents; Drug Discovery; Drug Evaluation, Preclinical; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Leishmania; Leishmania braziliensis; Leishmaniasis; Leukocytes; Meglumine Antimoniate; Microscopy, Confocal; Middle Aged; Monocytes; Neglected Diseases; Time Factors; Young Adult	2020
Aqueous ozone therapy improves the standard treatment of leishmaniasis lesions in animals leading to local and systemic alterations. Parasitology research, 2020, Volume: 119, Issue:12 Topics: Animals; Female; Immunomodulation; Leishmania mexicana; Leishmaniasis; Macrophages, Peritoneal; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Oxidants, Photochemical; Ozone; Parasite Load; Treatment Outcome; Wound Healing	2020
Influence of domperidone supplementation on short-term changes in C-reactive protein and paraoxonase-1 in dogs with leishmaniasis undergoing meglumine antimoniate and allopurinol therapy. Veterinary clinical pathology, 2020, Volume: 49, Issue:4 Topics: Allopurinol; Animals; Aryldialkylphosphatase; C-Reactive Protein; Dietary Supplements; Dog Diseases; Dogs; Domperidone; Leishmaniasis; Meglumine Antimoniate	2020
Serum cobalamin concentrations in dogs with leishmaniosis before and during treatment. Comparative immunology, microbiology and infectious diseases, 2021, Volume: 78 Topics: Allopurinol; Animals; Dog Diseases; Dogs; Leishmania infantum; Leishmaniasis; Leishmaniasis, Visceral; Meglumine Antimoniate; Vitamin B 12	2021
Antimony resistance associated with persistence of Leishmania (Leishmania) infantum infection in macrophages. Parasitology research, 2021, Volume: 120, Issue:8 Topics: Antimony; Drug Resistance; Humans; Leishmania infantum; Leishmaniasis; Macrophages; Meglumine Antimoniate	2021
Laryngeal leishmaniasis, a rare manifestation of an emerging disease. European annals of otorhinolaryngology, head and neck diseases, 2017, Volume: 134, Issue:3 Topics: Animals; Antiprotozoal Agents; Communicable Diseases, Emerging; Emergencies; Hoarseness; Humans; Laryngeal Diseases; Leishmania braziliensis; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Nasal Obstruction; Organometallic Compounds; Psychodidae; Tracheostomy; Treatment Outcome	2017
Identification of novel biomarkers for treatment monitoring in canine leishmaniosis by high-resolution quantitative proteomic analysis. Veterinary immunology and immunopathology, 2017, Volume: 191 Topics: Acute-Phase Proteins; Allopurinol; Animals; Antiprotozoal Agents; Biomarkers; Dog Diseases; Dogs; Female; Ferritins; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Proteomics; Serum Globulins	2017
Mannosylated thiolated polyethylenimine nanoparticles for the enhanced efficacy of antimonial drug against Leishmaniasis. Nanomedicine (London, England), 2018, Volume: 13, Issue:1 Topics: Antiprotozoal Agents; Biological Transport; Chitosan; Drug Carriers; Drug Liberation; Humans; Leishmania; Leishmaniasis; Mannose; Meglumine; Meglumine Antimoniate; Nanoparticles; Organometallic Compounds; Particle Size; Polyethyleneimine; Sulfhydryl Compounds; Surface Properties	2018
Changes in serum anti-Leishmania antibody concentrations measured by time-resolved immunofluorometric assays in dogs with leishmaniosis after treatment. Veterinary immunology and immunopathology, 2018, Volume: 198 Topics: Allopurinol; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Enzyme-Linked Immunosorbent Assay; Fluoroimmunoassay; Immunoglobulin A; Immunoglobulin G; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2018
The Elderly Respond to Antimony Therapy for Cutaneous Leishmaniasis Similarly to Young Patients but Have Severe Adverse Reactions. The American journal of tropical medicine and hygiene, 2018, Volume: 98, Issue:5 Topics: Adolescent; Adult; Aged; Brazil; Humans; Leishmaniasis; Meglumine Antimoniate; Middle Aged; Young Adult	2018
Canine leishmaniasis associated with pericardial effusion in a 4-year-old dog. Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology, 2019, Volume: 23 Topics: Allopurinol; Animals; Antiprotozoal Agents; Cardiac Tamponade; Dog Diseases; Dogs; Echocardiography; Leishmania; Leishmaniasis; Meglumine Antimoniate; Pericardial Effusion; Pericardial Fluid	2019
Biodistribution of meglumine antimoniate in healthy and Leishmania (Leishmania) infantum chagasi-infected BALB/c mice. Memorias do Instituto Oswaldo Cruz, 2013, Volume: 108, Issue:5 Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Female; Leishmania infantum; Leishmaniasis; Meglumine; Meglumine Antimoniate; Mice, Inbred BALB C; Organometallic Compounds; Radioisotopes; Radiopharmaceuticals; Time Factors; Tissue Distribution	2013
Paraoxonase activity as a tool for clinical monitoring of dogs treated for canine leishmaniasis. Veterinary journal (London, England : 1997), 2014, Volume: 199, Issue:1 Topics: Allopurinol; Animals; Antiprotozoal Agents; Aryldialkylphosphatase; Biomarkers; Case-Control Studies; Dog Diseases; Dogs; Drug Therapy, Combination; Enzyme Activation; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2014
Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia. PLoS neglected tropical diseases, 2014, Volume: 8, Issue:5 Topics: Adolescent; Adult; Aged; Antimony; Child; Child, Preschool; Cohort Studies; Colombia; Drug Resistance; Humans; Infant; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phosphorylcholine; Randomized Controlled Trials as Topic; Young Adult	2014
In vitro sensitivity of paired Leishmania (Viannia) braziliensis samples isolated before meglumine antimoniate treatment and after treatment failure or reactivation of cutaneous leishmaniasis. Disease markers, 2015, Volume: 2015 Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Female; Humans; Leishmania braziliensis; Leishmaniasis; Lethal Dose 50; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Skin	2015
Ex vivo host and parasite response to antileishmanial drugs and immunomodulators. PLoS neglected tropical diseases, 2015, Volume: 9, Issue:5 Topics: Adolescent; Animals; Antiprotozoal Agents; Female; Humans; Immunologic Factors; Interferon-alpha; Interleukin-10; Interleukin-13; Leishmania; Leishmaniasis; Leukocytes, Mononuclear; Macrophages; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine; Tumor Necrosis Factor-alpha; Young Adult	2015
Hair parasite load as a new biomarker for monitoring treatment response in canine leishmaniasis. Veterinary parasitology, 2016, Jun-15, Volume: 223 Topics: Animals; Antiprotozoal Agents; Biomarkers; Dog Diseases; Dogs; Hair; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasite Load	2016
TLR-2 and TLR-4 transcriptions in unstimulated blood from dogs with leishmaniosis due to Leishmania infantum at the time of diagnosis and during follow-up treatment. Veterinary parasitology, 2016, Sep-15, Volume: 228 Topics: Allopurinol; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Follow-Up Studies; Leishmania infantum; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasite Load; Parasitemia; Toll-Like Receptor 2; Toll-Like Receptor 4; Up-Regulation	2016
Serum apolipoprotein-A1 as a possible biomarker for monitoring treatment of canine leishmaniosis. Comparative immunology, microbiology and infectious diseases, 2016, Volume: 49 Topics: Allopurinol; Animals; Antiprotozoal Agents; Apolipoprotein A-I; Biomarkers; Dogs; Electrophoresis, Gel, Two-Dimensional; Leishmaniasis; Mass Spectrometry; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Proteome	2016
Meglumine antımoniate-TiO2@Ag nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect. Acta tropica, 2017, Volume: 169 Topics: Animals; Antiprotozoal Agents; Cell Line; Leishmania tropica; Leishmaniasis; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Nanoparticles; Organometallic Compounds; Titanium	2017
Evaluation of various biomarkers for kidney monitoring during canine leishmaniosis treatment. BMC veterinary research, 2017, Jan-23, Volume: 13, Issue:1 Topics: Allopurinol; Animals; Antimetabolites; Antiprotozoal Agents; Biomarkers; Dog Diseases; Dogs; Drug Therapy, Combination; Kidney Diseases; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Proteinuria	2017
Meglumine antimonate directly increases phagocytosis, superoxide anion and TNF-alpha production, but only via TNF-alpha it indirectly increases nitric oxide production by phagocytes of healthy individuals, in vitro. International immunopharmacology, 2008, Dec-10, Volume: 8, Issue:12 Topics: Adult; Antiprotozoal Agents; Female; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Monocytes; Neutrophils; Nitric Oxide; Organometallic Compounds; Phagocytosis; Superoxides; Tumor Necrosis Factor-alpha	2008
Extranodal gammadelta-T-cell lymphoma in a dog with leishmaniasis. Veterinary clinical pathology, 2008, Volume: 37, Issue:3 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Leishmaniasis; Lymphoma, T-Cell; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2008
Comparative study on the short term efficacy and adverse effects of miltefosine and meglumine antimoniate in dogs with natural leishmaniosis. Parasitology research, 2009, Volume: 105, Issue:1 Topics: Administration, Oral; Animals; Antiprotozoal Agents; Bone Marrow; Dog Diseases; Dogs; Female; Injections, Subcutaneous; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine	2009
[Leishmaniasis: hospital and population-based incidence, and asymptomatic infection. A disease that is still with us]. Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:2 Topics: Animals; Antiprotozoal Agents; Comorbidity; Disease Reservoirs; Dog Diseases; Dogs; Drug Utilization; HIV Infections; Humans; Incidence; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spain	2009
What is your diagnosis? Peritoneal effusion from a dog. Veterinary clinical pathology, 2009, Volume: 38, Issue:3 Topics: Allopurinol; Animals; Antiprotozoal Agents; Ascitic Fluid; Dog Diseases; Dogs; Female; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2009
Antileishmaniasis activity of flavonoids from Consolida oliveriana. Journal of natural products, 2009, Volume: 72, Issue:6 Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Flavonoids; Galactosides; Kaempferols; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Molecular Structure; Organometallic Compounds; Ranunculaceae; Rats; Rats, Inbred Strains; Turkey	2009
Administration of miltefosine and meglumine antimoniate in healthy dogs: clinicopathological evaluation of the impact on the kidneys. Toxicologic pathology, 2009, Volume: 37, Issue:6 Topics: Animals; Antiprotozoal Agents; Body Weight; Dogs; Female; Fluorescent Antibody Technique; Histocytochemistry; Kidney; Kidney Diseases; Kidney Tubules; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Microscopy, Electron; Organometallic Compounds; Phosphorylcholine; Random Allocation; Toxicity Tests	2009
Some remarks about the LeishVet directions for the treatment of canine leishmaniasis. Veterinary parasitology, 2010, May-11, Volume: 169, Issue:3-4 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Resistance; Guidelines as Topic; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2010
A 48-year-old man with laryngeal mass and vocal cord palsy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Jun-15, Volume: 50, Issue:12 Topics: Antiprotozoal Agents; HIV Infections; Humans; Laryngeal Diseases; Laryngeal Mucosa; Laryngoscopy; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Vocal Cord Paralysis	2010
Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol. Veterinary journal (London, England : 1997), 2011, Volume: 188, Issue:3 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Follow-Up Studies; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Severity of Illness Index; Time Factors; Treatment Outcome	2011
Disseminated leishmaniasis caused by Leishmania tropica in HIV-positive patients in the Islamic Republic of Iran. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 2010, Volume: 16, Issue:3 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiprotozoal Agents; Biopsy; CD4 Lymphocyte Count; Humans; Immunocompromised Host; Iran; Leishmania tropica; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Risk Factors; Substance Abuse, Intravenous; Travel	2010
Immunotherapy with Imiquimod increases the efficacy of Glucantime therapy of Leishmania major infection. Iranian journal of immunology : IJI, 2011, Volume: 8, Issue:1 Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antiprotozoal Agents; Drug Therapy, Combination; Imiquimod; Immunotherapy; Leishmania major; Leishmaniasis; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Treatment Outcome	2011
Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments. Parasites & vectors, 2011, Apr-13, Volume: 4 Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Europe; Female; Humans; Infectious Disease Transmission, Vertical; Leishmania infantum; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phlebotomus; Treatment Outcome	2011
Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages. International journal of antimicrobial agents, 2011, Volume: 38, Issue:4 Topics: Animals; Antiprotozoal Agents; Cell Survival; Cholesterol; Dose-Response Relationship, Drug; Drug Compounding; Drug Delivery Systems; Excipients; Fluorescence; Humans; Indicators and Reagents; Leishmania major; Leishmaniasis; Liposomes; Macrophages; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Organometallic Compounds; Oxazines; Phosphatidylserines; Xanthenes	2011
Novel approach to in vitro drug susceptibility assessment of clinical strains of Leishmania spp. Journal of clinical microbiology, 2012, Volume: 50, Issue:7 Topics: Antiprotozoal Agents; Cell Line; Humans; Leishmania; Leishmaniasis; Macrophages; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasite Load; Parasitic Sensitivity Tests; Phosphorylcholine; Temperature	2012
Novel immunomodulatory function of 1,3,4-thiadiazole derivatives with leishmanicidal activity. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:8 Topics: Animals; Antiprotozoal Agents; Cytokines; Disease Models, Animal; Histocytochemistry; Immunologic Factors; Injections, Intraperitoneal; Leishmaniasis; Liver; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Skin; Spleen; Thiadiazoles; Treatment Outcome	2012
Possible links between sickle cell crisis and pentavalent antimony. The American journal of tropical medicine and hygiene, 2012, Volume: 86, Issue:6 Topics: Anemia, Sickle Cell; Antimony; Child; Glutathione; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2012
Quinolinic alkaloids from Galipea longiflora Krause suppress production of proinflammatory cytokines in vitro and control inflammation in vivo upon Leishmania infection in mice. Scandinavian journal of immunology, 2013, Volume: 77, Issue:1 Topics: Alkaloids; Animals; Antigens, Protozoan; Antiprotozoal Agents; Cells, Cultured; Cytokines; Female; Immunosuppression Therapy; Inflammation Mediators; Leishmania braziliensis; Leishmaniasis; Lymphocyte Activation; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred C57BL; Organometallic Compounds; Parasite Load; Plant Extracts; Quinolines; Rutaceae; T-Lymphocytes	2013
Effects of the glucantime on the kinetic of biodistribution of radiopharmaceuticals in Wistar rats. Cellular and molecular biology (Noisy-le-Grand, France), 2002, Volume: 48, Issue:7 Topics: Animals; Antiprotozoal Agents; Drug Interactions; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Radiopharmaceuticals; Rats; Rats, Wistar; Technetium Tc 99m Medronate; Tissue Distribution	2002
Inhibition of parasite protein kinase C by new antileishmanial imidazolidin-2-one compounds. Journal of enzyme inhibition and medicinal chemistry, 2002, Volume: 17, Issue:6 Topics: Animals; Antiprotozoal Agents; Cells, Cultured; Enzyme Inhibitors; Fibroblasts; Humans; Imidazoles; Inhibitory Concentration 50; Leishmania; Leishmaniasis; Liver; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Protein Kinase C; Spleen; Structure-Activity Relationship	2002
[Parenteral glucantime therapy of bouton d'orient, with esthetic results superior to intralesional therapy]. Actas dermo-sifiliograficas, 1952, Volume: 43, Issue:8 Topics: Antimony; Esthetics; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1952
[N-methylglucamine antimoniate in the treatment of visceral leishmaniasis; first cases treated in Spain]. Revista cubana de pediatria, 1952, Volume: 24, Issue:7 Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spain	1952
[Note on the use of drugs with antimony base; a case of kala-azar treated with glucantime]. Archives francaises de pediatrie, 1954, Volume: 11, Issue:6 Topics: Antimony; Hypersensitivity; Immune System Diseases; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1954
[The activity of intramuscular glucantime and of intravenous anthiomaline in the treatment of sylvan American leishmaniasis]. Publication. Cayenne, French Guiana. Institut Pasteur de la Guyane francaise et de l'Inini, 1955, Volume: 16, Issue:353 Topics: Antimony; Furans; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1955
[Leishmaniasis mucocutaneous americana; our experience in its treatment with glucantime]. Prensa medica argentina, 1955, Jun-03, Volume: 42, Issue:22 Topics: Antimony; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1955
[Two cases of kala-azar treated with glucantime]. Acta pediatrica espanola, 1955, Volume: 13, Issue:155 Topics: Antimony; Child; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1955
[Test treatment with N-methylglucamine antimoniate in the diagnosis of kala-azar in children]. Hospital (Rio de Janeiro, Brazil), 1958, Volume: 54, Issue:3 Topics: Antimony; Child; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1958
[8 cases of kala-azar cured with glucantime]. Acta pediatrica espanola, 1962, Volume: 20 Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1962
[N-methylglucamine antimoniate (glucantime) in therapy of infantile visceral leishmaniasis; a further case of autocthonous infantile visceral leishmaniasis on the island of Elba]. Minerva dermatologica, 1955, Volume: 30, Issue:4 Topics: Antimony; Humans; Islands; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1955
[Treatment of cutaneous leishmaniasis by antimoniate of N-methyl glucamine; 15 personal observations]. Journal de medecine de Lyon, 1950, Sep-05, Volume: 31, Issue:736 Topics: Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1950
[Treatment of kala-azar by glucantime]. Cahiers medicaux de l'union francaise; revue medico-chirurgicale de la France d'outre-mer, 1950, Volume: 5, Issue:43 Topics: Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1950
[Polyneuritic complications after treatment of kala-azar in the adult with 2168 R.P]. Algerie medicale, 1951, Volume: 55, Issue:2 Topics: Adult; Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Neuritis; Organometallic Compounds; Polyneuropathies	1951
[Use of glucantime in infantile kala-azar]. Minerva pediatrica, 1951, Volume: 3, Issue:3 Topics: Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1951
[American cutaneo-mucous leishmaniasis; glucantime therapy; preliminary note]. Prensa medica argentina, 1951, Apr-06, Volume: 38, Issue:14 Topics: Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; United States	1951
Management of leishmanial osteolytic lesions in a hypothyroid dog by partial tarsal arthrodesis. The Veterinary record, 2004, Oct-30, Volume: 155, Issue:18 Topics: Allopurinol; Animals; Antiprotozoal Agents; Arthrodesis; Dog Diseases; Dogs; Hindlimb; Leishmania; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tarsal Joints; Treatment Outcome	2004
In vitro and in vivo cytotoxicities and antileishmanial activities of thymol and hemisynthetic derivatives. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:4 Topics: Animals; Antiprotozoal Agents; Cricetinae; Female; Humans; Leishmania; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Structure-Activity Relationship; Terpenes; Thymol; U937 Cells	2005
Granulomatous lesion on a bitch's nipple caused by Leishmania infantum. The Veterinary record, 2005, Mar-19, Volume: 156, Issue:12 Topics: Allopurinol; Animals; Breast Diseases; Dog Diseases; Dogs; Female; Leishmania infantum; Leishmaniasis; Meglumine; Meglumine Antimoniate; Nipples; Organometallic Compounds	2005
Role of residual Sb(III) in meglumine antimoniate cytotoxicity and MRP1-mediated resistance. Chemico-biological interactions, 2006, Apr-15, Volume: 160, Issue:3 Topics: Animals; Antimony; Antiprotozoal Agents; Cations; Cell Line; Drug Resistance, Microbial; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Multidrug Resistance-Associated Proteins; Organometallic Compounds	2006
Characterization of reactions of antimoniate and meglumine antimoniate with a guanine ribonucleoside at different pH. Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2006, Volume: 19, Issue:5 Topics: Animals; Antimony; Antiprotozoal Agents; Guanosine Monophosphate; Hydrogen-Ion Concentration; Leishmaniasis; Meglumine; Meglumine Antimoniate; Nuclear Magnetic Resonance, Biomolecular; Organometallic Compounds; Spectrometry, Mass, Electrospray Ionization; Thermodynamics	2006
Canine leishmaniasis chemotherapy: dog's clinical condition and risk of Leishmania transmission. Journal of veterinary medicine. A, Physiology, pathology, clinical medicine, 2006, Volume: 53, Issue:10 Topics: Allopurinol; Animals; Antiprotozoal Agents; Bone Marrow; Disease Transmission, Infectious; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Skin; Treatment Outcome; Trifluralin	2006
[Symptomatic hypokalemia caused by meglumine antimoniate]. Annales de dermatologie et de venereologie, 2007, Volume: 134, Issue:4 Pt 1 Topics: Antiprotozoal Agents; Female; Humans; Hypokalemia; Injections, Intramuscular; Leishmaniasis; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds	2007
Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol. Veterinary journal (London, England : 1997), 2008, Volume: 177, Issue:2 Topics: Allopurinol; Animals; Antiprotozoal Agents; DNA, Protozoan; Dog Diseases; Dogs; Drug Therapy, Combination; Leishmania; Leishmaniasis; Lymph Nodes; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; Skin	2008
Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride. Toxicology, 2008, Jan-14, Volume: 243, Issue:1-2 Topics: Animals; Antimony; Antiprotozoal Agents; Chlorides; Dose-Response Relationship, Drug; Kidney Diseases; Kidney Function Tests; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha	2008
Short communication: The cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Colombia in 2004. Tropical medicine & international health : TM & IH, 2007, Volume: 12, Issue:12 Topics: Antiprotozoal Agents; Colombia; Cost-Benefit Analysis; Disease Outbreaks; Hospital Costs; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2007
Leishmaniasis recidivans treated with sodium stibogluconate. Cutis, 1981, Volume: 28, Issue:1 Topics: Adult; Anti-Bacterial Agents; Antimony; Antimony Sodium Gluconate; Gluconates; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence	1981
[Cutaneous leishmaniasis in patients returning from the tropics]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1984, Feb-07, Volume: 73, Issue:6 Topics: Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Benzenesulfonates; Female; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Sulfamethoxazole; Travel; Tropical Climate	1984
[Successful intralesional treatment of leishmaniasis caused by Leishmania brasiliensis panamensis using glucantime]. Medicina cutanea ibero-latino-americana, 1984, Volume: 12, Issue:1 Topics: Adolescent; Adult; Aged; Antimony; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Infant, Newborn; Leishmania; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds	1984
[Experimental chemotherapy in cutaneous leishmaniasis. III. Effect of glucantime and humatin (P&D) on Leishmania garnhami and Leishmania braziliensis in hamsters]. Acta cientifica venezolana, 1984, Volume: 35, Issue:5-6 Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Drug Therapy, Combination; Female; Leishmania; Leishmaniasis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Sex Factors	1984
Toxicity and efficacy of the antileishmanial drug meglumine antimoniate in the owl monkey (Aotus trivirgatus). The Journal of parasitology, 1983, Volume: 69, Issue:6 Topics: Animals; Antimony; Antiprotozoal Agents; Aotus trivirgatus; Cebidae; Female; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Monkey Diseases; Organometallic Compounds	1983
Cutaneous leishmaniasis in mice: resistance to glucan immunotherapy, either alone or combined with chemotherapy. The American journal of tropical medicine and hygiene, 1982, Volume: 31, Issue:1 Topics: Animals; Antimony; Dose-Response Relationship, Immunologic; Female; Glucans; Immunotherapy; Leishmaniasis; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred C57BL; Mononuclear Phagocyte System; Organometallic Compounds; Sorbitol	1982
Disposition of antimony and aminosidine in dogs after administration separately and together: implications for therapy of leishmaniasis. Research in veterinary science, 1995, Volume: 58, Issue:2 Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Interactions; Female; Injections, Subcutaneous; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Models, Biological; Organometallic Compounds; Paromomycin	1995
Antimony determination in tissues and serum of hamsters infected with Leishmania garnhami and treated with meglumine antimoniate. Annals of tropical medicine and parasitology, 1994, Volume: 88, Issue:1 Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Injections, Intralesional; Injections, Intramuscular; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Tissue Distribution	1994
Synthesis of antimony complexes of yeast mannan and mannan derivatives and their effect on Leishmania-infected macrophages. The Biochemical journal, 1993, Jan-01, Volume: 289 ( Pt 1) Topics: Animals; Antimony; Antiprotozoal Agents; Carbohydrate Sequence; Cricetinae; Drug Carriers; Lectins, C-Type; Leishmania; Leishmaniasis; Macrophages; Mannans; Mannose; Mannose Receptor; Mannose-Binding Lectins; Meglumine; Meglumine Antimoniate; Mice; Molecular Sequence Data; Organometallic Compounds; Receptors, Cell Surface; Receptors, Immunologic; Saccharomyces cerevisiae	1993
2-substituted quinoline alkaloids as potential antileishmanial drugs. Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:4 Topics: Alkaloids; Animals; Antiprotozoal Agents; Female; Leishmania; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Quinolines	1993
Nitric oxide production in murine leishmaniasis: correlation of progressive infection with increasing systemic synthesis of nitric oxide. The American journal of tropical medicine and hygiene, 1996, Volume: 54, Issue:5 Topics: Animals; Antiprotozoal Agents; Body Weight; Disease Progression; Injections, Intraperitoneal; Leishmaniasis; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Nitric Oxide; Organometallic Compounds; Species Specificity	1996
Pharmacokinetics of liposome-encapsulated meglumine antimonate after intramuscular and subcutaneous administration in dogs. The American journal of tropical medicine and hygiene, 1997, Volume: 57, Issue:4 Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Carriers; Injections, Intramuscular; Injections, Subcutaneous; Leishmaniasis; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1997
[Torsade de pointes secondary to treatment with pentavalent antimonial drugs]. Medicina clinica, 1998, May-23, Volume: 110, Issue:18 Topics: Adult; Antiprotozoal Agents; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Torsades de Pointes	1998
Effects of antimonial therapy for canine leishmaniasis on antibody titer. Annals of the New York Academy of Sciences, 1998, Jun-29, Volume: 849 Topics: Allopurinol; Animals; Antibodies, Protozoan; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Injections, Intramuscular; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regression Analysis; Time Factors	1998
Genital ulcer in an AIDS patient with disseminated leishmaniasis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:11 Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Foot Ulcer; Humans; Leishmania; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Penile Diseases; Ulcer	1998
Physico-chemical characterization of meglumine antimoniate. Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 1999, Volume: 12, Issue:1 Topics: Antiprotozoal Agents; Hydrogen-Ion Concentration; Leishmaniasis; Magnetic Resonance Spectroscopy; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Potentiometry	1999
[Torsades de pointes during treatment of leishmaniasis with meglumine antimoniate]. Revista espanola de cardiologia, 1999, Volume: 52, Issue:7 Topics: Aged; Antimony; Antiprotozoal Agents; Electrocardiography; Female; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Torsades de Pointes	1999
[A 34-year-old man with lingual tumor. Lingual leishmaniasis in a patient with HIV infection]. Revista clinica espanola, 2001, Volume: 201, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Diagnosis, Differential; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Time Factors; Tongue Diseases; Treatment Outcome	2001
Monitoring of total antimony and its species by ICP-MS and on-line ion chromatography in biological samples from patients treated for leishmaniasis. Analytical and bioanalytical chemistry, 2002, Volume: 372, Issue:3 Topics: Adult; Antimony; Antiprotozoal Agents; Chromatography, Ion Exchange; Gas Chromatography-Mass Spectrometry; Hair; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds	2002
Leishmaniasis of the prepuce. Journal of the European Academy of Dermatology and Venereology : JEADV, 2002, Volume: 16, Issue:1 Topics: Antiprotozoal Agents; Diagnosis, Differential; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Penile Diseases	2002
In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate. BMC pharmacology, 2002, May-02, Volume: 2 Topics: Animals; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Resistance; Humans; Leishmania infantum; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests	2002
Interferon gamma therapy for cutaneous leishmaniasis. Archives of dermatology, 1990, Volume: 126, Issue:6 Topics: Animals; Antimony; Antiprotozoal Agents; Humans; Interferon-gamma; Leishmania tropica; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recombinant Proteins	1990
Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp. from patients unresponsive to pentavalent antimony therapy. The American journal of tropical medicine and hygiene, 1990, Volume: 43, Issue:5 Topics: Adenosine; Animals; Antimony Sodium Gluconate; Drug Resistance; Eflornithine; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1990
Diffuse cutaneous leishmaniasis acquired in Peru. The American journal of tropical medicine and hygiene, 1990, Volume: 43, Issue:3 Topics: Adult; Antimony; Antiprotozoal Agents; Biopsy; Female; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Peru; Skin	1990
[Cutaneous leishmaniasis: treatment with cryotherapy and intramuscular injections of meglumine antimonate (glucantime)]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1990, Volume: 41, Issue:2 Topics: Adult; Combined Modality Therapy; Cryosurgery; Female; Humans; Injections, Intramuscular; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Otitis Externa; Sorbitol	1990
Retention of antimony in skin biopsies of leishmaniasis patients after treatment with N-methylglucamine antimoniate. Clinical chemistry, 1990, Volume: 36, Issue:4 Topics: Adolescent; Adult; Aged; Antimony; Biopsy; Child; Double-Blind Method; Drug Administration Schedule; Humans; Injections, Intravenous; Leishmaniasis; Meglumine; Meglumine Antimoniate; Middle Aged; Neutron Activation Analysis; Organometallic Compounds; Random Allocation; Skin; Sorbitol	1990
Berberine derivatives as antileishmanial drugs. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:5 Topics: Animals; Antiprotozoal Agents; Berberine; Berberine Alkaloids; Body Weight; Cricetinae; Leishmaniasis; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Skin	1990
[Cutaneous leishmaniasis]. Revue medicale de la Suisse romande, 1989, Volume: 109, Issue:6 Topics: Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1989
An in vitro micromethod for drug sensitivity testing of Leishmania. The American journal of tropical medicine and hygiene, 1989, Volume: 41, Issue:3 Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Culture Media; Gluconates; Humans; Least-Squares Analysis; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regression Analysis; Sorbitol; Time Factors	1989
[Evaluation of the effectiveness and toxicity of pentostam and glucantime in the treatment of cutaneous leishmaniasis]. Revista medica de Panama, 1987, Volume: 12, Issue:3 Topics: Adult; Antimony Sodium Gluconate; Drug Evaluation; Female; Gluconates; Humans; Immunologic Techniques; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Random Allocation; Sorbitol	1987
Pentavalent antimonial treatment in mucosal leishmaniasis. Lancet (London, England), 1985, May-11, Volume: 1, Issue:8437 Topics: Antimony; Drug Administration Schedule; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Nifurtimox; Nitrofurans; Organometallic Compounds	1985
Recurrences of tegumentary leishmaniasis. Lancet (London, England), 1985, Sep-07, Volume: 2, Issue:8454 Topics: Antimony; Antiprotozoal Agents; Child; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence	1985
Kala azar with disseminated dermal leishmaniasis. The American journal of tropical medicine and hygiene, 1989, Volume: 40, Issue:2 Topics: Adolescent; Antiprotozoal Agents; Biopsy; Child; Female; Humans; Iran; Leishmaniasis; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin; Sorbitol	1989
[Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases]. Pathologie-biologie, 1985, Volume: 33, Issue:5 Pt 2 Topics: Adolescent; Adult; Antimony; Antimony Sodium Gluconate; Child; Child, Preschool; Female; Gluconates; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Splenectomy	1985
Glomerulonephritis in dogs with canine leishmaniasis. Annals of tropical medicine and parasitology, 1988, Volume: 82, Issue:4 Topics: Animals; Antiprotozoal Agents; Complement C3; Dog Diseases; Dogs; Glomerulonephritis; Immunoglobulin G; Kidney; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1988
[Leishmaniasis of the genital organs]. Medicina cutanea ibero-latino-americana, 1987, Volume: 15, Issue:2 Topics: Adult; Aged; Animals; Antiprotozoal Agents; Humans; Leishmania braziliensis; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Penile Diseases; Penile Neoplasms	1987
Cutaneous leishmaniasis in Bolivia. A study of 185 human cases from Alto Beni (La Paz Department). Isolation and isoenzyme characterization of 26 strains of Leishmania braziliensis braziliensis [corrected]. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1987, Volume: 81, Issue:5 Topics: Animals; Antiprotozoal Agents; Bolivia; Cricetinae; Humans; Leishmania; Leishmania braziliensis; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin	1987
[Culture systems for production of promastigote and amastigote forms of Leishmania. Application to serological diagnosis and therapeutic trials]. Annales de parasitologie humaine et comparee, 1986, Volume: 61, Issue:2 Topics: Animals; Antimony; Antiprotozoal Agents; Cell Line; Culture Media; Fluorescent Antibody Technique; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Serologic Tests; Time Factors	1986
The development of a vaccination model using two microorganisms and its application in leprosy and leishmaniasis. Leprosy review, 1986, Volume: 57 Suppl 2 Topics: Humans; Immunotherapy; Leishmania mexicana; Leishmaniasis; Leprosy; Meglumine; Meglumine Antimoniate; Mycobacterium leprae; Organometallic Compounds; Vaccination	1986
In vitro and in vivo anti-leishmanial activity of chlorpromazine alone and combined with N-meglumine antimonate. Annals of tropical medicine and parasitology, 1986, Volume: 80, Issue:5 Topics: Animals; Antiprotozoal Agents; Chlorpromazine; Drug Therapy, Combination; Leishmania; Leishmaniasis; Macrophages; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Organometallic Compounds; Sorbitol; Spleen	1986
Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases. The Journal of tropical medicine and hygiene, 1986, Volume: 89, Issue:6 Topics: Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Brazil; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1986